HUTCHMED (China) Limited has announced the disposal of a 45% equity interest in Shanghai Hutchison Pharmaceuticals Limited (SHPL). The transaction involves selling 35% of SHPL to GP Health Service ...

We recently compiled a list of the 12 Best Small Cap Pharma Stocks to Buy Now. In this article, we are going to take a look ...

Liver cancer in the Philippines holds a staggering mortality rate of 11.6 out of 100,000 individuals, compared to the global death rate of 7.8/100,000. This reflects the significant impact of liver ...

A Chinese woman made the unconventional decision to leave her lucrative job to pursue her passion for animals, becoming a ...

A notable NIH reform rolled out by Trump was a $4 billion cut to overhead funding for biomedical research by reducing ...

Stock analysts at HC Wainwright issued their FY2029 EPS estimates for Geron in a report released on Wednesday, February 26th. HC Wainwright analyst E. Bodnar anticipates that the biopharmaceutical ...

HC Wainwright reiterated their buy rating on shares of ACADIA Pharmaceuticals (NASDAQ:ACAD – Free Report) in a report ...

Dasgupta left India in 1985 and moved to the US to pursue an undergraduate degree that allowed her to major in biochemistry ...

We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at ...

1. Characterization of lipid components in lipid nanoparticle (LNP) formulations – Application Note AN001928 – an-001928-bt-lipid-components-LNP-an001928-na-en.pdf (SECURED) ...

Akeso begins patient enrolment in phase I trial of AK138 D1 for the treatment of advanced malignancies in Australia: Hong Kong Saturday, March 1, 2025, 12:00 Hrs [IST] Akeso, Inc.

The Novato-based maker of biopharmaceutical treatments for rare diseases plans to release this year a new gene therapy for ...